.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Eisai Inc Company Profile

« Back to Dashboard

Summary for Applicant: Eisai Inc

Patents:30
Tradenames:13
Ingredients:11
NDAs:17
Drug Master File Entries: (click here to view)7
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911-002Nov 14, 2008RXNo<disabled><disabled>
Eisai Inc
ARICEPT ODT
donepezil hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021720-001Oct 18, 2004RXNo<disabled><disabled>
Eisai Inc
BANZEL
rufinamide
SUSPENSION;ORAL201367-001Mar 3, 2011RXYes6,740,669*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc